First Biosimilar of Inhalation Solution for Cystic Fibrosis Treatment Approved

被引：0
|
作者：
不详
机构：
来源：
BIOPHARM INTERNATIONAL | 2019年 / 32卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [1] Tobramycin inhalation product approved for use in cystic fibrosis therapy
    Nightingale, SL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (09): : 645 - 645
  • [2] Aztreonam Lysine Inhalation Solution in Cystic Fibrosis
    Elson, Elizabeth Claire
    Mermis, Joel
    Polineni, Deepika
    Oermann, Christopher M.
    [J]. CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2019, 13
  • [3] Tobramycin Inhalation Solution (Bethkis) for Cystic Fibrosis
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1445): : 51 - 52
  • [4] Aztreonam Lysine for Inhalation Solution In Cystic Fibrosis
    Plosker, Greg L.
    [J]. DRUGS, 2010, 70 (14) : 1843 - 1855
  • [5] Aztreonam for Inhalation Solution (Cayston) for Cystic Fibrosis
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1344): : 63 - 64
  • [6] First Tysabri biosimilar approved
    不详
    [J]. NURSE PRACTITIONER, 2023, 48 (11): : 48 - 48
  • [7] First Biosimilar Product Approved
    Rubin, Rita
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (15): : 1507 - 1507
  • [8] FIRST PEGFILGRASTIM BIOSIMILAR APPROVED
    Aschenbrenner, Diane S.
    [J]. AMERICAN JOURNAL OF NURSING, 2018, 118 (10) : 19 - 20
  • [9] FIRST BIOSIMILAR DRUG APPROVED
    不详
    [J]. AMERICAN JOURNAL OF NURSING, 2015, 115 (07) : 24 - 24
  • [10] Sphingolipids as targets for inhalation treatment of cystic fibrosis
    Becker, Katrin Anne
    Riethmueller, Joachim
    Seitz, Aaron P.
    Gardner, Aaron
    Boudreau, Ryan
    Kamler, Markus
    Kleuser, Burkhard
    Schuchman, Edward
    Caldwell, Charles C.
    Edwards, Michael J.
    Grassme, Heike
    Brodlie, Malcolm
    Gulbins, Erich
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2018, 133 : 66 - 75
12345